• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Phaarmasia Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2597.0
  • ISIN : INE486I01016
29.61 -1 (-3.89%)
  • As on 26 Jul 2025 (EOD)
  • Today’s Low

    29.60
  • Today’s High

    30.81
  • Open

    30.81
  • Perv Close

    30.81
  • 52W Low

    23.60
  • 52W High

    64.53

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    20.22

  • Div & Yield %

    0.00

  • Book Value(₹)

    6.59

  • Debt-Equity Ratio

    -3.89

  • AGM Date

    25-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    20.22

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.83

  • BV (₹)

    6.60

  • Sales( ₹ in Cr.)

    24.37

  • NP (in Cr.)

    -1.59

  • NP Var(%)

    -207.0

  • Div%

    0.0

  • CPS (₹)

    -1.90

  • EPS (₹)

    -2.30

  • Traded Value (₹ in Lakhs)

    20.22

  • 52 Week High

    64.53

  • 52 Week Low

    23.60

  • Price BSE

    30.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.22

  • P/C Ratio

    -16.10

  • P/E Ratio

    -12.90

  • Price Vs.BV

    -2.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 30.59 27.49 17.22 16.26 19.93 25.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 1.46
Net Sales 30.59 27.49 17.22 16.26 19.93 24.19
Other Income 0.66 0.52 0.47 0.89 0.58 0.60
Stock Adjustments -0.60 1.67 0.49 -2.09 0.55 1.68
Total Income 30.65 29.68 18.18 15.06 21.06 26.47
EXPENDITURE :            
Raw Materials 24.01 24.13 14.35 12.49 18.35 17.88
Power and Fuel Cost 0.77 0.73 0.53 0.58 0.90 0.98
Employee Cost 1.53 1.41 1.17 1.36 1.40 1.55
Other Manufacturing Expenses 2.86 2.73 1.97 2.29 2.10 2.05
Selling and Administration Expenses 1.66 1.71 1.43 -2.49 -3.08 2.68
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expenses 1.53 1.41 1.17 1.36 1.40 1.55
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 30.82 30.71 19.44 14.23 19.67 25.15
Operating Profit -0.16 -1.03 -1.27 0.83 1.40 1.33
Interest 0.04 0.04 0.00 0.01 0.04 0.04
Gross Profit -0.20 -1.07 -1.27 0.82 1.36 1.29
Depreciation 0.34 0.36 0.29 0.34 0.40 0.46
Profit Before Tax -0.54 -1.43 -1.56 0.48 0.96 0.83
Current Tax 0.00 0.00 0.00 0.18 0.27 0.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.03 -0.17 -0.02 -0.02 0.16 -0.20
Reported Net Profit -0.52 -1.26 -1.55 0.31 0.54 0.78
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.02
Adjusted Net Profit -0.52 -1.26 -1.55 0.31 0.54 0.76
Adjustment below Net Profit 0.01 -0.01 0.31 0.00 0.00 0.00
P & L Balance brought forward -1.00 0.28 1.51 1.51 0.97 0.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.51 -1.00 0.28 1.82 1.51 0.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.76 -1.84 -2.27 0.46 0.79 1.14
Earnings Per Share(Adj)-Unit Curr -0.76 -1.84 -2.27 0.46 0.79 1.14
Book Value 8.87 9.62 11.45 13.79 13.43 12.56
Book Value(Adj)-Unit Curr 8.87 9.62 11.45 13.79 13.43 12.56

Shareholding Pattern

  • Promoter Group

    73.51%

  • Public Share Holding

    26.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,018,732 73.51 5,018,732 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,018,732 73.51 5,018,732 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 240 0.00 0 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,720 0.05 0 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,960 0.06 0 7
2] Non Institution
Bodies Corporate 10,118 0.15 5,667 59
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,035 0.10 7,035 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 396,888 5.81 268,165 7
Individuals holding nominal share capital up to Rs. 1 lakh 1,366,139 20.01 420,584 20,388
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 24,088 0.35 24,088 37
Sub Total 1,804,268 26.43 725,539 20,503
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,826,960 100.00 5,744,271 20,512

Company Background

Phaarmasia LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Phaarmasia Ltd
  • BSE Code : 2597.0
  • ISIN : INE486I01016
  • Incorporation Year

    1981

  • Registered Office

    16 Phase III
    I D A Jeedimetla, Hyderabad,
    Telangana-500055

  • Telephone

    91-40-23095002/23095690

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Urvashi Bhatia

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Phaarmasia Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Phaarmasia 29.61 31.25 30.59 -12.71 0.00
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10